Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valérie Dutoit

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Cancer Immunity|May 16, 2003
Functional analysis of HLA-A*0201/Melan-A peptide multimer+ CD8+ T cells isolated from an HLA-A*0201- donor: exploring tumor antigen allorestricted recognitionValérie Dutoit, Philippe Guillaume, Pedro Romero, et al.
European Journal of Immunology|January 31, 2003
Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomesValérie Dutoit, Philippe Guillaume, Jean-Charles Cerottini, et al.
International Journal of Cancer|April 8, 2009
Limits of CD133 as a marker of glioma self-renewing cellsVirginie Clément, Valérie Dutoit, Denis Marino, et al.
European Journal of Immunology|November 24, 2005
Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infectionValérie Dutoit, Donatella Ciuffreda, Denis Comte, et al.
Current Opinion in Oncology|August 27, 2010
T-cell immunotherapy for malignant glioma: toward a combined approachPierre-Yves Dietrich, Valérie Dutoit, Nhu Nam Tran Thang, et al.
Current Opinion in Pharmacology|March 5, 2019
Peptides as cancer vaccinesMarta Calvo Tardón, Mathilde Allard, Valérie Dutoit, et al.
Cancers|April 17, 2019
Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma PatientsEmma Boydell, Eliana Marinari, Denis Migliorini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 10, 2023
Radio-chemotherapy of glioblastoma cells promotes phagocytosis by macrophages in vitroMarc Lecoultre, Sylvie Chliate, Felipe I Espinoza, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rateValérie Dutoit, Philippe Guillaume, Maha Ayyoub, et al.
Immunological Reviews|July 11, 2006
Functional signatures of protective antiviral T-cell immunity in human virus infectionsAlexandre Harari, Valérie Dutoit, Cristina Cellerai, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Cancer Immunity|May 16, 2003
Functional analysis of HLA-A*0201/Melan-A peptide multimer+ CD8+ T cells isolated from an HLA-A*0201- donor: exploring tumor antigen allorestricted recognitionValérie Dutoit, Philippe Guillaume, Pedro Romero, et al.
European Journal of Immunology|January 31, 2003
Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomesValérie Dutoit, Philippe Guillaume, Jean-Charles Cerottini, et al.
International Journal of Cancer|April 8, 2009
Limits of CD133 as a marker of glioma self-renewing cellsVirginie Clément, Valérie Dutoit, Denis Marino, et al.
European Journal of Immunology|November 24, 2005
Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infectionValérie Dutoit, Donatella Ciuffreda, Denis Comte, et al.
Current Opinion in Oncology|August 27, 2010
T-cell immunotherapy for malignant glioma: toward a combined approachPierre-Yves Dietrich, Valérie Dutoit, Nhu Nam Tran Thang, et al.
Current Opinion in Pharmacology|March 5, 2019
Peptides as cancer vaccinesMarta Calvo Tardón, Mathilde Allard, Valérie Dutoit, et al.
Cancers|April 17, 2019
Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma PatientsEmma Boydell, Eliana Marinari, Denis Migliorini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 10, 2023
Radio-chemotherapy of glioblastoma cells promotes phagocytosis by macrophages in vitroMarc Lecoultre, Sylvie Chliate, Felipe I Espinoza, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rateValérie Dutoit, Philippe Guillaume, Maha Ayyoub, et al.
Immunological Reviews|July 11, 2006
Functional signatures of protective antiviral T-cell immunity in human virus infectionsAlexandre Harari, Valérie Dutoit, Cristina Cellerai, et al.
Pageof 7